How to Buy Organogenesis Holdings Stock
Organogenesis Holdings Inc
Organogenesis Holdings Inc. , a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States.
Organogenesis Holdings stock last closed at $2.29, down 23.32% from the previous day, and has increased 16.58% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.25 percentage points. Organogenesis Holdings stock is currently +22.19% from its 52-week low of $1.87, and -51.43% from its 52-week high of $4.71.
At the moment, there are 131.96M shares of ORGO outstanding. The market cap of ORGO is $301.54M. In the last 24 hours, 2.55M ORGO shares were traded.
How to Buy Organogenesis Holdings Stock
Wondering how to invest in Organogenesis Holdings stock? Here's how.
- Figure out where to buy Organogenesis Holdings stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Organogenesis Holdings stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Choose your method of payment and add your information.
- Analyze Organogenesis Holdings stock: The Organogenesis Holdings ticker symbol is ORGO. Is Organogenesis Holdings stock a good investment? Should you buy shares of ORGO? How do ORGO's underlying business fundamentals look? Do top analysts think Organogenesis Holdings is a good buy? Why has ORGO's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if ORGO is a good stock to buy).
- Make your ORGO purchase: Decide if you will purchase ORGO shares at the current market price or use a limit order to purchase ORGO shares at a specific price.
- Watch your investment in ORGO: Create a watchlist to track your position in Organogenesis Holdings shares.
Step 1: Figure out where to buy Organogenesis Holdings stock
You need a brokerage account in order to access the NASDAQ market and buy ORGO shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Utilities, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro today.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal details so you can buy ORGO stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start your new brokerage account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have created your account on the best stock investing app, your next step is to transfer the money for your investment:
Check out the tutorial below for more details transferring funds into your new investment account.
Step 4: Analyze Organogenesis Holdings stock
Once you have chosen the best place to buy Organogenesis Holdings stock, it's absolutely critical to analyze their stock before you invest, so you actually understand the risk and opportunity.
Organogenesis Holdings shares quick numbers
Organogenesis Holdings Due Diligence Checks
WallStreetZen was created to help average investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ORGO's stock page.
How is ORGO stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge ORGO's intrinsic value.
Using relative valuations methods:
- ORGO may be overvalued based on its P/E ratio of 57.13x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 33.56x
- ORGO may be undervalued based on its P/B ratio of 1.08x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.07x
You can do additional valuation research on ORGO's stock here.
Is ORGO a healthy company?
Passed Health Checks:
- Total ORGO debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the ORGO balance sheet.
- There are more short-term assets than short-term liabilities on the ORGO balance sheet.
- ORGO earnings of $12.58M is not enough to cover its interest payments.
- ORGO's operating cash flow of $30.92M allows it to safely service it's debt of $119.35M.
Failed Health Checks:
- ORGO has a relatively high debt to equity ratio of 0.65.
- ORGO profit margin has gone down from 3.4% to 1.1% in the past year.
Is ORGO stock a Buy, Hold, or Sell, according to analysts?
Out of 3 sell side analysts who give ratings on ORGO, the consensus analyst rating on ORGO is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Organogenesis Holdings stock forecast page.
ORGO Trading Indicators
ORGO Performance Metrics
Last year, ORGO earnings were $4.95M. Over the past three year, ORGO's earnings have grown by -90.86% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of -9.55%.
Last year, ORGO revenue was $433.14M. In the last five year, ORGO's revenue has gone up by 17.49% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.67%.
Find out more about ORGO's earnings and revenue performance here.
Who is buying/selling ORGO?
Over the last 12 months, executives and large shareholders at ORGO have sold more shares than they have bought.
Patrick Bilbo, Chief Operating Officer of ORGO, was the latest ORGO insider to sell. They sold $6,991.60 worth of ORGO stock on Apr 1, 2024.
Get more info about who owns ORGO shares here.
Can I rely on ORGO as an income stream?
No, Organogenesis Holdings doesn't provide an income stream by paying out dividends.
What do other traders have to say about ORGO?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your ORGO purchase
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally sufficient. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, place a limit order.
Press the Open button and your broker will execute your order.
If you require more help investing in stocks on eToro, click the how to video below:
Step 6: Watch your investment in ORGO
Now that you own some ORGO stock, you'll want to keep up with your new investment.
Create a watchlist to track your ORGO stock.
ORGO Feed
How to Buy Stock in Organogenesis Holdings
To summarize, here are the 6 steps to buy stock in Organogenesis Holdings:
- Figure out where to buy Organogenesis Holdings stock
- Open a brokerage account
- Put funds into your brokerage account
- Analyze Organogenesis Holdings stock
- Make your ORGO purchase
- Watch your investment in ORGO
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Organogenesis Holdings, hit the button below to create your watchlist.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.